PSEN1 and Alzheimer disease: A study using iPSC lines generated from familiar AD patients revealed increased Aβ42:40 in all, but quantitatively and qualitatively divergent Aβ secretomes, and that distinct presenilin 1 (PSEN1) mutations caused different alterations, altogether culminating in the reduction in γ-secretase carboxypeptidase-like activity [27].